© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity

Top section
More articles

More articles

More articles

  • SRI
    European financial regulators have bowed to pressure from investment firms and their trade bodies, and look set to weaken the requirements of the Sustainable Finance Disclosure Regulation, a central part of the EU's Sustainable Finance Action Plan.
  • Huge demand for exposure to biotech companies among US equity investors is continuing to drive UK firms to list on the other side of the Atlantic through an IPO on the Nasdaq. On Thursday, Immunocore, a late-stage biotech firm focused on T-cell technology, priced an enlarged offering on the exchange and, on Friday, UK healthcare investor Syncona announced it was exploring a US IPO for one of its portfolio companies.
  • Hipgnosis Songs Fund, a London-listed investment trust focused on music royalties, has closed its latest share sale, raising £75m.
  • Medical device manufacturer New Horizon Health has pulled in early demand to cover its Hong Kong IPO multiple times over, according to a source familiar with the matter.
  • Thai Beverage is preparing to spin off and list its brewery business, BeerCo, on the Singapore Exchange in a deal expected to raise as much as $2bn.
  • Under its new "Strategy 2024" plan, Commerzbank is considering outsourcing equities services to a partner as several rivals have done. It also wants to focus its equity capital markets and M&A franchises more squarely on existing clients.
shared comment list